• Markets
    • icon
  • Companies
ARX · ASX

Aroa Biosurgery Ltd (ASX:ARX)

AU$0.72

 -0.005 (-0.694%)
ASX:Live
28/11/2023 04:10:31 PM
Hammer Bearish HALO Ords HALO Earnings Momentum HALO Balance Sheet GROWTH AUS +4
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ARX Overview

ARX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About ARX

Website

Aroa Biosurgery Ltd

Telephone

64.9.869.3035

Address

64 Richard Pearse Drive Mangere, Auckland 2022

Description

Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.

ARX Price Chart

Key Stats

Market Cap

AU$230.11M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.63 - 1.25

Trade Value (12mth)

US$47,412.00

1 week

7.46%

1 month

-4.95%

YTD

-34.55%

1 year

-31.75%

All time high

1.745

Key Fundamentals

EPS 3 yr Growth

-862.700%

EBITDA Margin

-14.10%

Operating Cashflow

-$12m

Free Cash Flow Return

-13.80%

ROIC

-10.10%

Interest Coverage

-4.90

Quick Ratio

11.30

Other Data

Shares on Issue (Fully Dilluted)

359m

HALO Sector

Healthcare

Next Company Report Date

29-May-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.00

ARX Announcements

Latest Announcements

Date Announcements

31 October 23

September 2023 Quarterly Report and Appendix 4C

×

September 2023 Quarterly Report and Appendix 4C

31 October 23

Investor Presentation

×

Investor Presentation

31 October 22

Change of Registry Address

×

Change of Registry Address

31 May 23

FY23 Appendix 4E and Full Year Results

×

FY23 Appendix 4E and Full Year Results

31 May 23

FY23 Full Year Results Presentation

×

FY23 Full Year Results Presentation

31 March 23

Notification regarding unquoted securities - ARX

×

Notification regarding unquoted securities - ARX

31 March 23

Change of Director's Interest Notice - JD

×

Change of Director's Interest Notice - JD

31 March 23

Change of Director's Interest Notice - PM

×

Change of Director's Interest Notice - PM

31 March 23

Change of Director's Interest Notice - BW

×

Change of Director's Interest Notice - BW

31 March 23

Change of Director's Interest Notice - JM

×

Change of Director's Interest Notice - JM

31 March 23

Change of Director's Interest Notice - JP

×

Change of Director's Interest Notice - JP

31 March 23

Change of Director's Interest Notice - SE

×

Change of Director's Interest Notice - SE

31 July 23

June 2023 Quarterly Report and Appendix 4C

×

June 2023 Quarterly Report and Appendix 4C

31 January 23

December 2022 Quarterly Report and Appendix 4C

×

December 2022 Quarterly Report and Appendix 4C

31 January 23

Investor Presentation

×

Investor Presentation

31 August 23

Section 708A Notice

×

Section 708A Notice

31 August 23

Application for quotation of securities - ARX

×

Application for quotation of securities - ARX

31 August 23

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

30 June 23

Annual Report to Shareholders

×

Annual Report to Shareholders

30 June 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 June 22

Annual Report to Shareholders

×

Annual Report to Shareholders

30 June 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 July 20

Investor Presentation - July 2020

×

Investor Presentation - July 2020

29 November 22

Appendix 4D and Half Year Report

×

Appendix 4D and Half Year Report

29 November 22

Aroa Biosurgery Half Yearly Results H1 FY23

×

Aroa Biosurgery Half Yearly Results H1 FY23

29 November 22

Aroa Half Year Results Presentation

×

Aroa Half Year Results Presentation

29 July 21

Investor Presentation

×

Investor Presentation

29 April 22

AROA BIOSURGERY TO PRESENT AT NWR VIRTUAL CONFERENCE

×

AROA BIOSURGERY TO PRESENT AT NWR VIRTUAL CONFERENCE

ARX Fundamentals

Per Share Records

Historical data

Forecasted data

NZD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.06 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.06 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -719.0 -221.4 61.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.02 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.7 -259.4 82.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -1.6 -5.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.19 0.29 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.04 0.13 0.24 Lock Lock Lock
     Growth % Lock Lock Lock Lock -41.7 452.1 80.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 300 300 342 Lock Lock Lock
Basic m Lock Lock Lock Lock 300 300 342 Lock Lock Lock

Financial Records

Historical data

Forecasted data

NZD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock 25 22 40 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.6 -10.9 77.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 21 26 39 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 18 15 30 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.2 -18.2 100.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 73.4 67.4 76.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 27 33 24 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 0 -8 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -112.3 -3,352.0 30.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.9 -35.7 -14.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 3 3 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -11 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1,449.0 -271.8 21.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -11.9 -49.5 -22.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -6 -19 -8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -6 -19 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -720.6 -222.4 56.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -23.8 -86.0 -21.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 2 -5 -12 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 2 5 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -22 -35 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 37 38 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 -6 -16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 98.0 -20,129.2 -154.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 -0.3 -0.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 37 57 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 46 80 113 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 3 6 5 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 5 -21 -52 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 38 21 12 Lock Lock Lock
Equity $m Lock Lock Lock Lock 8 58 99 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 11 64 106 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.8 506.0 64.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -13.0 -24.1 -7.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -76.8 -33.4 -8.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -18.5 -23.8 -9.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -51.0 -51.8 -10.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 14.2 -13.5 -13.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

NZD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -1.0 -18.6 -4.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -21.1 2.6 9.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 62.7 -36.0 -52.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.5 3.2 11.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.4 3.0 11.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 33.4 75.8 71.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 4.7 -32.7 -171.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.8 3.0 3.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.0 1.9 2.6 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A 0.7 0.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.9 3.3 3.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.3 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.3 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -24.6 -85.5 -20.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -13.4 -24.0 -7.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -13.0 -24.1 -7.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 5.9 1.4 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -76.8 -33.4 -8.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -33.4 -8.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 185.9 193.4 142.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 95.0 120.8 110.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 281.0 314.2 252.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 38.2 54.0 37.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 242.8 260.1 215.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ARX Shortsell

Frequently Asked Questions

The current share price of Aroa Biosurgery Ltd (ARX:ASX) is AU$0.72.
The 52-week high share price for Aroa Biosurgery Ltd (ARX:ASX) is AU$1.25.
The 52-week low share price for Aroa Biosurgery Ltd (ARX:ASX)? is AU$0.63.
Aroa Biosurgery Ltd (ARX:ASX) does not pay a dividend.
Aroa Biosurgery Ltd (ARX:ASX) does not pay a dividend.
Aroa Biosurgery Ltd (ARX:ASX) has a franking level of 0%.
Aroa Biosurgery Ltd (ARX:ASX) is classified in the Healthcare.
The current P/E ratio for Aroa Biosurgery Ltd (ARX:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.